EquivocalALKfluorescencein-situhybridization (FISH) cases may benefit from ancillaryALKFISH probe testing
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EquivocalALKfluorescencein-situhybridization (FISH) cases may benefit from ancillaryALKFISH probe testing
Authors
Keywords
-
Journal
HISTOPATHOLOGY
Volume 67, Issue 5, Pages 654-663
Publisher
Wiley
Online
2015-04-04
DOI
10.1111/his.12708
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progression-free survival (PFS) from a phase I study of crizotinib (PF-02341066) in patients with ALK-positive non-small cell lung cancer (NSCLC).
- (2017) D. R. Camidge et al. JOURNAL OF CLINICAL ONCOLOGY
- EML4-ALK Fusion Lung Cancer: A Rare Acquired Event
- (2015) Sven Perner et al. NEOPLASIA
- Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated withALK‘borderline’-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategies
- (2014) M. I. Ilie et al. ANNALS OF ONCOLOGY
- Detection of ALK expression in non-small-cell lung cancer withALKgene rearrangements - comparison of multiple immunohistochemical methods
- (2014) Karen Zwaenepoel et al. HISTOPATHOLOGY
- Accurate Identification of ALK Positive Lung Carcinoma Patients: Novel FDA-Cleared Automated Fluorescence In Situ Hybridization Scanning System and Ultrasensitive Immunohistochemistry
- (2014) Esther Conde et al. PLoS One
- Native and rearranged ALK copy number and rearranged cell count in non-small cell lung cancer
- (2013) D. Ross Camidge et al. CANCER
- Combined Use of ALK Immunohistochemistry and FISH for Optimal Detection of ALK-Rearranged Lung Adenocarcinomas
- (2013) Lynette M. Sholl et al. Journal of Thoracic Oncology
- Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization
- (2013) Christina I Selinger et al. MODERN PATHOLOGY
- Correlations between the percentage of tumor cells showing an anaplastic lymphoma kinase (ALK) gene rearrangement,ALKsignal copy number, and response to crizotinib therapy inALKfluorescence in situ hybridization-positive nonsmall cell lung cancer
- (2012) D. Ross Camidge et al. CANCER
- Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer
- (2012) Andrew J. Weickhardt et al. CANCER
- Immunohistochemistry is a Reliable Screening Tool for Identification of ALK Rearrangement in Non–Small-Cell Lung Carcinoma and is Antibody Dependent
- (2012) Chris M.J. Conklin et al. Journal of Thoracic Oncology
- A Novel, Highly Sensitive Antibody Allows for the Routine Detection of ALK-Rearranged Lung Adenocarcinomas by Standard Immunohistochemistry
- (2010) M. Mino-Kenudson et al. CLINICAL CANCER RESEARCH
- Optimizing the Detection of Lung Cancer Patients Harboring Anaplastic Lymphoma Kinase (ALK) Gene Rearrangements Potentially Suitable for ALK Inhibitor Treatment
- (2010) D. R. Camidge et al. CLINICAL CANCER RESEARCH
- The biology and treatment of EML4-ALK non-small cell lung cancer
- (2010) Takaaki Sasaki et al. EUROPEAN JOURNAL OF CANCER
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statistical Treatment of Fluorescence in Situ Hybridization Validation Data to Generate Normal Reference Ranges Using Excel Functions
- (2009) Allison L. Ciolino et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search